TRISODIUM 5-(ACETYLAMINO)-4-HYDROXY-3-(2-(4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)DIAZENYL)-2,7-NAPHTHALENEDISULFONATE
UNII ESA8D2BC6W
Substance Identification & Data
This profile provides standardized clinical and technical data for Trisodium 5-(acetylamino)-4-hydroxy-3-(2-(4-(((3-((2-(sulfooxy)ethyl)sulfonyl)phenyl)amino)carbonyl)phenyl)diazenyl)-2,7-naphthalenedisulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ESA8D2BC6W.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80419-51-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H21N4O15S4.3Na DPEUGRLBPCIGMU-HUVHLSCJSA-K Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Trisodium 5-(acetylamino)-4-hydroxy-3-(2-(4-(((3-((2-(sulfooxy)ethyl)sulfonyl)phenyl)amino)carbonyl)phenyl)diazenyl)-2,7-naphthalenedisulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.